FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071263587> ?p ?o ?g. }

• W2071263587 endingPage "606" @default.
• W2071263587 startingPage "598" @default.
• W2071263587 abstract "To evaluate the efficacy and safety of etoricoxib and indomethacin in the treatment of patients with acute gout.A randomized, double-blind, active-comparator study was conducted at 42 sites. A total of 189 men and women (> or =18 years of age) who were experiencing an acute attack (< or =48 hours) of clinically diagnosed gout were treated for 8 days with etoricoxib, 120 mg/day (n = 103), or indomethacin, 50 mg 3 times a day (n = 86). The primary efficacy end point was the patient's assessment of pain in the study joint (0-4-point Likert scale) over days 2-5. Safety was assessed by adverse experiences (AEs) occurring during the trial.Etoricoxib demonstrated clinical efficacy comparable to that of indomethacin in terms of the patient's assessment of pain in the study joint. The difference in the mean change from baseline over days 2-5 was -0.08 (95% confidence interval -0.29, 0.13) (P = 0.46), which fell within the prespecified comparability bounds of -0.5 to 0.5. Secondary end points over the 8-day study, including the onset of efficacy, reduction in signs of inflammation, and patient's and investigator's global assessments of response to therapy, confirmed the comparable efficacy of the two treatments. The etoricoxib-treated patients had a numerically lower incidence of AEs (43.7%) than did the indomethacin-treated patients (57.0%) and a significantly lower incidence of drug-related AEs (16.5% versus 37.2%; P < 0.05).Etoricoxib at a dosage of 120 mg once daily was confirmed to be an effective treatment for acute gout. Etoricoxib was comparable in efficacy to indomethacin at a dosage of 50 mg 3 times daily, and it was generally safe and well tolerated." @default.
• W2071263587 created "2016-06-24" @default.
• W2071263587 creator A5007653088 @default.
• W2071263587 creator A5014809059 @default.
• W2071263587 creator A5017128204 @default.
• W2071263587 creator A5020849424 @default.
• W2071263587 creator A5023220117 @default.
• W2071263587 creator A5034041802 @default.
• W2071263587 creator A5047080636 @default.
• W2071263587 creator A5059837134 @default.
• W2071263587 creator A5061181148 @default.
• W2071263587 creator A5062128433 @default.
• W2071263587 creator A5068700484 @default.
• W2071263587 creator A5072813670 @default.
• W2071263587 date "2004-02-01" @default.
• W2071263587 modified "2023-09-23" @default.
• W2071263587 title "Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: A randomized controlled trial" @default.
• W2071263587 cites W1966776934 @default.
• W2071263587 cites W1968569444 @default.
• W2071263587 cites W1974179017 @default.
• W2071263587 cites W1981816788 @default.
• W2071263587 cites W1984891090 @default.
• W2071263587 cites W2002008824 @default.
• W2071263587 cites W2007189186 @default.
• W2071263587 cites W2011392312 @default.
• W2071263587 cites W2013069358 @default.
• W2071263587 cites W2019650183 @default.
• W2071263587 cites W202378911 @default.
• W2071263587 cites W2040089021 @default.
• W2071263587 cites W2042612482 @default.
• W2071263587 cites W2044334793 @default.
• W2071263587 cites W2064951559 @default.
• W2071263587 cites W2084347081 @default.
• W2071263587 cites W2093225750 @default.
• W2071263587 cites W2101346705 @default.
• W2071263587 cites W2103796156 @default.
• W2071263587 cites W2112391342 @default.
• W2071263587 cites W2137981468 @default.
• W2071263587 cites W2167382292 @default.
• W2071263587 cites W2268058582 @default.
• W2071263587 cites W2330496155 @default.
• W2071263587 cites W3134263331 @default.
• W2071263587 cites W3190028774 @default.
• W2071263587 cites W4239321191 @default.
• W2071263587 doi "https://doi.org/10.1002/art.20007" @default.
• W2071263587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14872504" @default.
• W2071263587 hasPublicationYear "2004" @default.
• W2071263587 type Work @default.
• W2071263587 sameAs 2071263587 @default.
• W2071263587 citedByCount "161" @default.
• W2071263587 countsByYear W20712635872012 @default.
• W2071263587 countsByYear W20712635872013 @default.
• W2071263587 countsByYear W20712635872014 @default.
• W2071263587 countsByYear W20712635872015 @default.
• W2071263587 countsByYear W20712635872016 @default.
• W2071263587 countsByYear W20712635872017 @default.
• W2071263587 countsByYear W20712635872018 @default.
• W2071263587 countsByYear W20712635872019 @default.
• W2071263587 countsByYear W20712635872020 @default.
• W2071263587 countsByYear W20712635872021 @default.
• W2071263587 countsByYear W20712635872022 @default.
• W2071263587 countsByYear W20712635872023 @default.
• W2071263587 crossrefType "journal-article" @default.
• W2071263587 hasAuthorship W2071263587A5007653088 @default.
• W2071263587 hasAuthorship W2071263587A5014809059 @default.
• W2071263587 hasAuthorship W2071263587A5017128204 @default.
• W2071263587 hasAuthorship W2071263587A5020849424 @default.
• W2071263587 hasAuthorship W2071263587A5023220117 @default.
• W2071263587 hasAuthorship W2071263587A5034041802 @default.
• W2071263587 hasAuthorship W2071263587A5047080636 @default.
• W2071263587 hasAuthorship W2071263587A5059837134 @default.
• W2071263587 hasAuthorship W2071263587A5061181148 @default.
• W2071263587 hasAuthorship W2071263587A5062128433 @default.
• W2071263587 hasAuthorship W2071263587A5068700484 @default.
• W2071263587 hasAuthorship W2071263587A5072813670 @default.
• W2071263587 hasBestOaLocation W20712635871 @default.
• W2071263587 hasConcept C120665830 @default.
• W2071263587 hasConcept C121332964 @default.
• W2071263587 hasConcept C126322002 @default.
• W2071263587 hasConcept C141071460 @default.
• W2071263587 hasConcept C168563851 @default.
• W2071263587 hasConcept C197934379 @default.
• W2071263587 hasConcept C203092338 @default.
• W2071263587 hasConcept C2776214540 @default.
• W2071263587 hasConcept C2780402116 @default.
• W2071263587 hasConcept C42219234 @default.
• W2071263587 hasConcept C44249647 @default.
• W2071263587 hasConcept C61511704 @default.
• W2071263587 hasConcept C71924100 @default.
• W2071263587 hasConceptScore W2071263587C120665830 @default.
• W2071263587 hasConceptScore W2071263587C121332964 @default.
• W2071263587 hasConceptScore W2071263587C126322002 @default.
• W2071263587 hasConceptScore W2071263587C141071460 @default.
• W2071263587 hasConceptScore W2071263587C168563851 @default.
• W2071263587 hasConceptScore W2071263587C197934379 @default.
• W2071263587 hasConceptScore W2071263587C203092338 @default.
• W2071263587 hasConceptScore W2071263587C2776214540 @default.
• W2071263587 hasConceptScore W2071263587C2780402116 @default.

• next